The combination of Aceclofenac and Paracetamol is commonly used to provide symptomatic relief by simultaneously addressing multiple components of physical discomfort, making it relevant across several distinct therapeutic domains. Its core purpose is to help with symptoms related to physical discomfort and inflammatory or irritative states.

Relief for Inflammatory Joint and Musculoskeletal Disorders

This medicine is commonly used in adults to help with the symptoms related to physical discomfort and inflammatory or irritative states associated with chronic conditions like osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as acute issues like sprains and strains. It supports relief by addressing the underlying inflammation, which may assist with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.

Quick Fact: Relief for Pain and Inflammation

Support for Acute, Episodic, and Post-Procedural Pain

ACPC is commonly used across conditions presenting with acute episodes when short-term symptomatic assistance is needed, particularly for mild to moderate pain and swelling. This includes applied scenarios such as relief from acute lower backache, severe menstrual pain (dysmenorrhea), and discomfort experienced following minor interventions, including dental extractions. It helps maintain a sense of stability when symptoms that interfere with daily functioning become noticeable.

Reduction of Pain Accompanied by Fever

The combination is relevant for managing symptom clusters that may become intense or disruptive, especially where fever accompanies physical discomfort. The medication is relevant in contexts involving heightened systemic burden, where supportive symptom management is appropriate for both pain and fever, providing assistance during difficult episodes by easing distress. It is commonly used to help with symptoms related to physical discomfort in conditions presenting with feverishness, headache, and general body aches.

Who Can and Cannot Use Acpc? Official Eligibility Information

Official regulatory documents define strict population eligibility for Acpc (Aceclofenac/Paracetamol). Use is established for adults but is not recommended for children due to insufficient clinical data. The elderly population requires caution due to increased risk of serious complications.

Contraindicated Populations (Must Not Use)	Restricted/Conditional Use (Use with Caution)
Known hypersensitivity to Aceclofenac, Paracetamol, or other NSAIDs.	Mild to moderate hepatic, renal, or cardiac impairment.
Severe heart, kidney, or liver insufficiency.	History of peptic ulcers or inflammatory bowel disease (Crohn's/Colitis).
Active GI bleeding or recurrent peptic ulceration.	Uncontrolled hypertension or established cardiovascular disease.
Women in the third trimester of pregnancy.	Women in the first or second trimester of pregnancy and those breastfeeding (not recommended).

The medicine is contraindicated in these high-risk groups to prevent severe outcomes. For all other restricted populations, regulatory caution emphasizes the need for careful medical consideration before use is permitted.

Interactions with other medicines and products

This section summarizes the officially documented interactions for ACPC (Aceclofenac/Paracetamol) as specified in government regulatory labeling, focusing on pharmacokinetic and pharmacodynamic constraints.

Contraindicated Combinations

Co-administration with other Non-steroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 inhibitors, is formally prohibited due to an increased risk of gastrointestinal bleeding and ulceration. A strict prohibition also applies to co-administering any other Paracetamol-containing products to prevent accidental overdose and subsequent hepatotoxicity. Enhanced hepatotoxicity risk requires the avoidance of alcohol.

Clinically Significant Interactions

Mechanism Type	Interacting Agents	Official Constraint
Pharmacodynamic Risk	Anticoagulants (e.g., Warfarin), SSRIs, Corticosteroids	Increased risk of hemorrhage, bleeding, or GI ulceration.
Clearance Reduction	Lithium, Methotrexate	Reduced renal clearance, leading to increased plasma concentrations of Lithium or Methotrexate.
Renal Function	Diuretics, Antihypertensives, Ciclosporin, Tacrolimus	Risk of impaired renal function and potential attenuation of blood pressure control.

Timing and Population Notes

The absorption rate of Paracetamol is reduced by Cholestyramine, requiring administration separation of at least one hour. Elderly patients are officially noted to have a heightened risk for adverse reactions, particularly renal and gastrointestinal complications, when taking interacting agents like diuretics or anticoagulants. The risk of Paracetamol toxicity is also heightened in patients with hepatic impairment when combined with enzyme inducers.

Acpc (1-aminocyclopropanecarboxylic acid) functions as a partial agonist at the glycine-binding site of the N-methyl-D-aspartate (NMDA) receptor complex, which is a ligand-gated ion channel primarily localized in the central nervous system. By occupying this modulatory site on the NMDA receptor's NR1 subunit, Acpc promotes the receptor's conformational change, thereby increasing the open probability of the ion channel pore.

This interaction facilitates the flux of positive ions, primarily Ca^2+ and Na^+, into the postsynaptic neuron. The resultant increase in intracellular calcium concentration initiates multiple intracellular signaling cascades, including those involving calcium-dependent kinases and phosphatases, ultimately modulating neuronal excitability and synaptic plasticity. At a system level, this leads to the non-selective physiological modulation of glutamatergic neurotransmission across multiple brain regions.

The ACPC fixed-dose combination tablet is intended for oral administration and is supplied as a film-coated tablet. The administration schedule outlines the dose, frequency, and conditions for intake.

Administration Parameter	Official Instruction
Standard Adult Dose	One tablet taken twice daily (morning and evening).
Maximum Daily Limit	Total Aceclofenac component must not exceed 200 mg per day.
Contextual Intake	To be taken preferably with or immediately after food.
Preparation Rule	Must be swallowed whole with liquid; do not crush or chew.

The overall use protocol emphasizes employing the lowest effective dose for the shortest duration necessary to control symptoms. Adjustments are typically made for certain patient groups: the daily dose is reduced for individuals with hepatic impairment, corresponding to one tablet taken once daily. Furthermore, the medicine is not recommended for use in children and adolescents due to a lack of established safety and efficacy data for the combination product. In the event of a missed timing, a double dose should not be taken to compensate.

Research Evidence / Overview of Studies for ACPC

---

Evidence for Use in Acute Pain Conditions

The research base for Acpc includes systematic reviews and clinical studies that have been applied in studies examining patient-reported experiences of acute pain. These studies were used in research exploring how symptoms change over time in the adult patient group experiencing sudden and disruptive episodes. Research examined outcomes related to physical discomfort and symptom intensity.

The findings describe patterns observed in the studies where the fixed-dose combination was observed in trials that evaluated short-term symptom patterns. Research highlights changes measured during the study period related to the outcomes related to physical discomfort.

Evidence for Use in Inflammatory Joint and Musculoskeletal Disorders

Acpc was evaluated in studies relevant to conditions characterized by fluctuating or episodic manifestations, such as rheumatoid arthritis, osteoarthritis, and acute muscle sprains and strains. Clinical studies monitored outcomes linked to inflammatory or irritative states and outcomes reflecting daily functioning or activity level. The available research describes patterns of measurements relating to outcomes linked to inflammatory or irritative states for the targeted conditions.

Evidence for Managing Symptom Clusters Involving Pain and Fever

Research explored the dual composition of Acpc, which was studied for conditions associated with acute or disruptive episodes where fever was studied for concurrent physical discomfort. These studies examined outcomes reflecting both fever reduction and concurrent outcomes related to systemic or functional imbalance in adults. The studies describe patterns of how symptoms evolved in the observed populations, indicating that the combination was observed in trials focusing on these symptom clusters.

---

What Is Still Uncertain About the Research for ACPC

The majority of the evidence available is derived from studies focusing on episodes where symptoms become more noticeable. A central research gap is that long-term effects are not fully established, as follow-up durations were limited in many core trials. Additionally, data for certain groups, such as children or adolescents, remain insufficient, and comparative evidence is lacking for some specific subgroups. The research contributes to the broader evidence landscape but highlights areas where studies are ongoing.

Key Studies & References

1. A Review of Aceclofenac: Analgesic and Anti-Inflammatory Effects on Musculoskeletal Disorders
2. The efficacy and safety of paracetamol for pain relief: an overview of systematic reviews
3. Prescription trends of aceclofenac as a standalone or in combination with paracetamol for managing arthritis in Indian settings

Common questions about Acpc (FAQ)

Q: How quickly does Acpc start working after the first use?

According to official product information, the aceclofenac component typically reaches its highest concentration in the blood within 1.25 to 3.00 hours after a person takes the tablet. This measurement indicates the approximate time needed for the medicine to become fully available in the bloodstream.

Q: How long does the effect of one dose of Acpc usually last?

The prescribed schedule of taking this medicine twice daily is based on pharmacological data. Official studies show that the average time for the concentration of the aceclofenac component to reduce by half (its half-life) is approximately 4 hours, which guides the frequency of intake.

Q: Is it true that Acpc can affect sleep patterns?

Official documents from regulatory bodies list drowsiness as a common side effect of this medicine. This is a potential effect that relates to sleep and wakefulness.

Q: Does Acpc interact with caffeine or alcohol?

Regulatory guidance indicates that the consumption of alcohol should be avoided due to the potential for increased drowsiness and a heightened risk of liver damage. Specific product information does not list caffeine as a major interaction.

Q: Can women who are planning pregnancy use Acpc?

Official safety documents indicate that the aceclofenac component may impair female fertility. Due to this potential effect, regulatory information states that the medicine is not recommended for use in women who are actively attempting to conceive.

Q: Is Acpc commonly used in countries outside the US?

This medicine is globally established and approved by regulatory bodies in multiple jurisdictions, including various countries in the European Union and Asia. Regulatory documents indicate that the fixed-dose combination product is not currently approved for use in the United States.

Q: What should I do if I accidentally take too much Acpc?

Official documents emphasize that in the event of an accidental overdose, immediate medical attention is required. This is because an overdose can cause serious adverse effects, including the potential for liver failure.

Q: Is Acpc in the same class of drugs as [Similar Drug Name]?

This medicine is a fixed-dose combination product, meaning it contains two different types of active ingredients. It is classified as a blend of a Non-steroidal Anti-inflammatory Drug (NSAID) and a non-opioid analgesic/antipyretic medicine.

Q: What is the main difference between Acpc and other options for the same condition?

The primary unique feature of this medicine is its dual composition. It contains two distinct active ingredients: the anti-inflammatory component (Aceclofenac) and the pain-relieving/fever-reducing component (Paracetamol).

Q: Are there any vitamins or supplements that should not be taken with Acpc?

Regulatory guidance states the principle of informing a healthcare professional about all drugs, vitamins, and supplements being used. This principle exists because the medicine has documented interactions with various medicinal products.

Q: Can Acpc affect lab results like blood tests?

Regulatory documents include documented adverse reactions that may be detected through routine blood tests. These reactions include changes such as elevated liver enzymes and increases in blood urea or creatinine levels.

Q: Does Acpc contain lactose or gluten?

The exact list of inactive ingredients, or excipients, including substances like lactose or gluten, is detailed in the medicine's official Summary of Product Characteristics (SmPC). This document provides all composition details as reviewed by regulators.

Q: Is Acpc habit-forming or is there a risk of dependence?

According to its pharmacological classification, the medicine is a combination of a Non-steroidal Anti-inflammatory Drug and a non-opioid analgesic. It is not classified as a controlled substance and does not carry a risk of dependence.

Q: Is it normal to feel a mild headache when first starting Acpc?

Headache is noted in official documentation as a Rare adverse reaction to this medicine. Adverse reactions are classified by their frequency, and 'Rare' indicates an event occurring in less than 1 in 1,000 people.

Q: Does Acpc affect blood pressure?

Official safety documents list hypertension (high blood pressure) as a Rare adverse reaction to the medicine. Furthermore, regulatory guidance states that monitoring is required for patients who already have a history of hypertension.

Q: What are the typical expected benefits from Acpc?

The general purpose of this medicine, as described in official documentation, is to provide relief for pain, inflammation, and fever. It is utilized in conditions associated with musculoskeletal strain or inflammatory disorders.

Q: Are there any long-term effects of taking Acpc for several years?

Official labeling states that for long-term treatment, regular monitoring of renal function, hepatic function (liver), and blood counts is required. Additionally, regulatory documents note that long-term use of NSAIDs may be associated with a small increased risk of arterial thrombotic events.

Q: How often are follow-up appointments usually needed when on Acpc?

While regulatory documents do not specify the exact frequency of clinical follow-up appointments, they do require regular monitoring for individuals receiving long-term treatment. This monitoring includes checking renal function, hepatic function, and blood counts.

How to Store and Dispose of ACPC Tablets (Aceclofenac/Paracetamol)

Official regulatory guidelines define specific conditions for the storage and disposal of ACPC tablets to maintain product stability and safety.

Storage Requirements

The medicine must be stored at a temperature below 30°C and should be protected from light and moisture. To maintain product integrity, the tablets must remain in their original container or packaging. It is a mandatory child-safety measure that the medicine be kept out of the sight and reach of children at all times.

Disposal Instructions

Any unused or expired ACPC product must be handled as pharmaceutical waste and discarded according to local regulations. The medicine should not be disposed of using the household wastewater system, such as by flushing down a toilet.